Resmed Inc
NYSE:RMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Resmed Inc
NYSE:RMD
|
US |
|
Magic Software Enterprises Ltd
NASDAQ:MGIC
|
IL |
|
N
|
Nepi Rockcastle NV
JSE:NRP
|
NL |
|
T
|
Telstra Group Ltd
F:5KB
|
AU |
|
Crown Holdings Inc
NYSE:CCK
|
US |
|
Noble Corporation PLC
CSE:NOBLE
|
US |
Wall St Price Targets
RMD Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RMD is 276.03 USD with a low forecast of 181.8 USD and a high forecast of 357 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RMD's stock price target?
Price Target
276.03
USD
According to Wall Street analysts, the average 1-year price target for RMD is 276.03 USD with a low forecast of 181.8 USD and a high forecast of 357 USD.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 6 years is 7%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 6 years is 12%.
